RxSight completes 3.8M-share option exchange
RxSight completed its employee option exchange, cancelling 3.76 million option shares and issuing new options and RSUs under its 2021 Equity Incentive Plan.
Rhea-AI Filing Summary
RxSight, Inc. (RXST) reports the final results of its employee option exchange offer. The offer expired at 9:00 p.m. Pacific Time on September 4, 2026, with 205 eligible employees tendering options to purchase an aggregate of 3,761,461 shares of common stock, representing 91.9% of the shares underlying eligible options held by eligible employees.
On September 5, 2026, RxSight granted options to purchase 1,643,324 shares of common stock to its named executive officers and restricted stock units covering 760,738 shares of common stock to non-executive employees, in each case in exchange for the cancelled options and pursuant to the company’s 2021 Equity Incentive Plan.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
Exchange Offer financial
Eligible Options financial
restricted stock units financial
2021 Equity Incentive Plan financial
FAQ
What did RxSight, Inc. (RXST) announce in Amendment No. 2 to its Schedule TO?
How many new options did RxSight (RXST) grant to named executive officers after the exchange?
What equity awards did RxSight (RXST) grant to non-executive employees in the exchange?
What proportion of eligible RxSight (RXST) options participated in the exchange offer?
AI-generated analysis. How Rhea-AI works. Not financial advice.